Efficacy and Safety of Diode Laser Transscleral Cyclophotocoagulation in Patients with Glaucoma
TSCPC can be an effective IOP-lowering procedure, demonstrating a stronger effect when the preoperative IOP is highest. However, there is a wide variability in the effect (specially in eyes with NVG) and some relevant complications, including 8.3% of patients developing phthisis bulbi after 2 years of follow up.
Authors
- Flávio R.F. Alves (ORCID: https://orcid.org/0000-0002-9922-8202)
- João Tavares-Ferreira (ORCID: https://orcid.org/0000-0002-5283-2939)
- Mário Lima-Fontes (ORCID: https://orcid.org/0000-0002-9126-3505)
- Marta Inês Silva
- João Barbosa‐Breda (ORCID: https://orcid.org/0000-0001-7816-816X)
- Mariana Leuzinger-Dias (ORCID: https://orcid.org/0000-0002-9361-0195)
- Joana Araújo (ORCID: https://orcid.org/0000-0001-9649-3177)
- Sérgio Estrela‐Silva (ORCID: https://orcid.org/0000-0002-7415-813X)
- Margarida Ribeiro (ORCID: https://orcid.org/0000-0002-0196-3840)
- António Melo (ORCID: https://orcid.org/0009-0000-4550-8500)
- João Nogueira Freitas
Institutions
- Universidade do Porto (PT)
- KU Leuven (BE)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2024-08-01
- DOI
- https://doi.org/10.2147/opth.s473788
- Citations
- 1
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.54